Promising Result from a Novel Mezigdomide Combination Trial | Fredrik Schjesvold, MD, PhD | #EHA2025

Promising Result from a Novel Mezigdomide Combination Trial | Fredrik Schjesvold, MD, PhD | #EHA2025
MagnetisMM-6: Elranatamab+Dara+Len in ND Transplant-Ineligible MM | Meletios Dimopoulos, MD | #EHA2025
MagnetisMM-6: Elranatamab+Dara+Len in ND Transplant-Ineligible MM | Meletios Dimopoulos, MD | #EHA2025
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in Myeloma | Meletios Dimopoulos, MD | #EHA2025
Updated DREAMM-8 Data: Belantamab-Pomalidomide-Dex in Myeloma | Meletios Dimopoulos, MD | #EHA2025
Real-World Evidence for Teclistamab in Myeloma | Dr. Rakesh Popat Shares #EHA2025 Insights
Real-World Evidence for Teclistamab in Myeloma | Dr. Rakesh Popat Shares #EHA2025 Insights
First-In-Human Study for Novel Trispecific Antibody | Rakesh Popat, BSc, MBBS, MRCP, PhD | #EHA2025
First-In-Human Study for Novel Trispecific Antibody | Rakesh Popat, BSc, MBBS, MRCP, PhD | #EHA2025
What is extramedullary disease and how is it treated?
Is it safe to be intimate with your partner who is on chemo and radiation?
Are there any foods, drinks, or supplements that individuals on myeloma therapy should avoid?